9 days ago
DNTH
AnalystsYatin SunejaYatin Suneja's Stock Forecasts
AnalystsYatin Suneja
Analyst Ranking
Top 3%
#109 out of 5216 analysts
Average Return
+29.04%
Win Rate
59%89 out of 152
Risk vs Reward
Poor
Good
Yatin Suneja's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alumis IncALMS | +644.94% | $3.36 | $25.03 | 2025-06-10 - 2026-03-12 | Strong Buy |
Zura Bio LtdZURA | +408.61% | $1.34 | $6.79 | 2025-03-26 - 2026-03-12 | Strong Buy |
Reata Pharmaceuticals IncRETA | +376.00% | $36.21 | $172.36 | 2022-10-19 - 2023-09-25 | Strong Buy |
Dianthus Therapeutics IncDNTH | +291.96% | $21.90 | $85.84 | 2025-03-12 - 2026-03-11 | Strong Buy |
Phathom Pharmaceuticals IncPHAT | +270.29% | $2.76 | $10.22 | 2025-05-02 - 2026-03-12 | Strong Buy |
Yatin Suneja Analyst Color
Get additional color on Yatin Suneja's coverage of popular stocks
14 days ago
PHAT
a month ago
PRAX
2 months ago
ALMS
3 months ago
DBVT
3 months ago
PRAX
4 months ago
IFRX
5 months ago
PRAX
5 months ago
ABVX
5 months ago
ACET
6 months ago
ROIV
7 months ago
NBIX
7 months ago
ARGX
8 months ago
ABVX
a year ago
ARGX
a year ago
SYRE
2 years ago
CLDX
2 years ago
AXSM
2 years ago
LBPH
3 years ago
ARGX
3 years ago
ARGX
3 years ago
LRMR
3 years ago
RXDX
Yatin Suneja's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dianthus Therapeutics IncDNTH | 3 | Strong Buy | $200.00 | +149.00% | Maintains | 9 days ago |
Sionna Therapeutics IncSION | 1 | Strong Buy | $50.00 | +36.31% | Maintains | 10 days ago |
Phathom Pharmaceuticals IncPHAT | 4 | Strong Buy | $25.00 | +144.62% | Maintains | 14 days ago |
Argenx SeARGX | 12 | Strong Buy | $1,120.00 | +58.00% | Maintains | 14 days ago |
Axsome Therapeutics IncAXSM | 9 | Strong Buy | $220.00 | +42.75% | Maintains | 17 days ago |
Praxis Precision Medicines IncPRAX | 5 | Strong Buy | $800.00 | +163.70% | Maintains | a month ago |
Regeneron Pharmaceuticals IncREGN | 9 | Strong Buy | $975.00 | +30.59% | Maintains | a month ago |
Biogen IncBIIB | 4 | Strong Buy | $246.00 | +33.04% | Maintains | a month ago |
Roivant Sciences LtdROIV | 4 | Strong Buy | $30.00 | +5.08% | Maintains | a month ago |
Immunovant IncIMVT | 5 | Strong Buy | $44.00 | +76.07% | Maintains | a month ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $50.00 | +199.22% | Initiates Coverage On | a month ago |
Alumis IncALMS | 3 | Strong Buy | $32.00 | +27.85% | Maintains | 2 months ago |
Sab Biotherapeutics IncSABS | 1 | Strong Buy | $15.00 | +226.80% | Initiates Coverage On | 3 months ago |
Dbv Technologies SaDBVT | 2 | Strong Buy | $51.00 | +154.24% | Maintains | 3 months ago |
Inflarx NvIFRX | 4 | Strong Buy | $22.00 | +2,142.61% | Maintains | 4 months ago |
Anaptysbio IncANAB | 10 | Strong Buy | $100.00 | +56.76% | Maintains | 4 months ago |
Neumora Therapeutics IncNMRA | 2 | Strong Buy | $14.00 | +345.86% | Upgrades | 5 months ago |
Rapt Therapeutics IncRAPT | 3 | Strong Buy | $70.00 | +20.65% | Initiates Coverage On | 5 months ago |
Oruka Therapeutics IncORKA | 1 | Strong Buy | $60.00 | +87.56% | Initiates Coverage On | 5 months ago |
Abivax SaABVX | 3 | Strong Buy | $150.00 | +28.23% | Maintains | 5 months ago |
Adicet Bio IncACET | 3 | Strong Buy | $128.00 | +1,718.18% | Maintains | 5 months ago |
Moonlake ImmunotherapeuticsMLTX | 4 | Strong Buy | $20.00 | +17.44% | Maintains | 5 months ago |
Tourmaline Bio IncTRML | 3 | Hold | $48.00 | +0.04% | Downgrades | 6 months ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $75.00 | +176.55% | Initiates Coverage On | 7 months ago |
Cabaletta Bio IncCABA | 6 | Strong Buy | $15.00 | +370.22% | Maintains | 7 months ago |
Neurocrine Biosciences IncNBIX | 6 | Strong Buy | $175.00 | +36.95% | Maintains | 7 months ago |
Larimar Therapeutics IncLRMR | 6 | Strong Buy | $26.00 | +445.07% | Reiterates | 9 months ago |
Gh Research PLCGHRS | 1 | Strong Buy | $29.00 | +86.86% | Maintains | 10 months ago |
Zura Bio LtdZURA | 2 | Strong Buy | $15.00 | +120.91% | Reiterates | a year ago |
Zenas Biopharma IncZBIO | 2 | Strong Buy | $45.00 | N/A | Reiterates | a year ago |
Surrozen IncSRZN | 3 | Strong Buy | $45.00 | N/A | Upgrades | a year ago |
Spyre Therapeutics IncSYRE | 1 | Strong Buy | $65.00 | N/A | Maintains | a year ago |
Vigil Neuroscience IncVIGL | 2 | Strong Buy | $16.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 2 years ago |
Celldex Therapeutics IncCLDX | 4 | Strong Buy | $90.00 | N/A | Maintains | 2 years ago |
Longboard Pharmaceuticals IncLBPH | 3 | Strong Buy | $32.00 | N/A | Maintains | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $49.00 | N/A | Reiterates | 3 years ago |
Eyepoint IncEYPT | 2 | Strong Buy | $55.00 | N/A | Maintains | 3 years ago |
Bioxcel Therapeutics IncBTAI | 2 | Strong Buy | $736.00 | N/A | Maintains | 3 years ago |
Prometheus Biosciences IncRXDX | 3 | Hold | $200.00 | N/A | Downgrades | 3 years ago |
Acadia Pharmaceuticals IncACAD | 5 | Strong Buy | $22.00 | N/A | Upgrades | 3 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Hold | $116.50 | N/A | Downgrades | 3 years ago |
Sage Therapeutics IncSAGE | 3 | Strong Buy | $48.00 | N/A | Maintains | 3 years ago |
Reata Pharmaceuticals IncRETA | 1 | Strong Buy | $75.00 | N/A | Initiates Coverage On | 3 years ago |
Relmada Therapeutics IncRLMD | 3 | Hold | N/A | N/A | Downgrades | 3 years ago |
Karuna Therapeutics IncKRTX | 1 | Strong Buy | $330.00 | N/A | Maintains | 4 years ago |
Bausch & Lomb CorpBLCO | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 4 years ago |
Climb Bio IncCLYM | 2 | Hold | N/A | N/A | Downgrades | 4 years ago |
Seelos Therapeutics IncSEELQ | 1 | Strong Buy | $30,720.00 | N/A | Initiates Coverage On | 5 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 7 years ago |
Seagen IncSGEN | 1 | Strong Buy | $80.00 | N/A | Upgrades | 8 years ago |
Verona Pharma PLCVRNA | 1 | Strong Buy | $26.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.